The latest price target for Streamline Health Solns (NASDAQ:STRM) was reported by Lake Street on November 21, 2022. The analyst firm set a price target for $3.00 expecting STRM to rise to within 12 months (a possible 29.87% upside). 0 analyst firms have reported ratings in the last year.

The latest analyst rating for Streamline Health Solns (NASDAQ:STRM) was provided by Lake Street, and Streamline Health Solns their buy rating.

There is no last upgrade for Streamline Health Solns

There is no last downgrade for Streamline Health Solns.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Streamline Health Solns, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Streamline Health Solns was filed on November 21, 2022 so you should expect the next rating to be made available sometime around November 21, 2023.

While ratings are subjective and will change, the latest Streamline Health Solns (STRM) rating was a with a price target of $0.00 to $3.00. The current price Streamline Health Solns (STRM) is trading at is $2.31, which is within the analyst’s predicted range.